Reagents
Ended Awarded Last action
- Contract number
- W81K0220F0253
- Awardee
-
Immucor Inc. UEI KV8AGJX7NMZ7
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $107,635
Award facts
- Opportunity
-
- W81K0220Q0223 Solicitation number
- Sole Source Award Notice for Complement Control Cells, FMH Rapid Screen Kits, and Reagents Award Notice · Posted Sep 27, 2020
- Contract value 100% obligated
- $107,634.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Norcross, GA 30091, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $35,878 | |
| Exercise an Option | $0 | |
| Funding Only Action | $35,878 | |
| Exercise an Option | $0 | |
| Funding Only Action | $35,878 | |
| Original award | $0 |
About this award
This is a federal contract awarded by the Defense Health Agency to Immucor Inc., a for-profit organization and manufacturer of goods. The contract is for the delivery of reagents under the Invitro Diagnostics, Reagents, Test Federal Supply Schedule (FSS-65-VII). The contract has a firm fixed price of $107,634.54 and a completion date of September 30, 2023. Immucor Inc. has a history of providing specialized reagents, blood analyzers, testing equipment, and related consumables to support blood typing, compatibility testing, antibody screening, and blood banking operations for federal health networks and military treatment centers. This award is not set aside and may be part of a larger indefinite delivery vehicle that facilitates the recurring purchase of essential blood banking supplies on an as-needed basis.
Quick answers
Who was awarded contract W81K0220F0253?
W81K0220F0253 was awarded to Immucor Inc. by Medical Command (Department of the Army) on October 1, 2020.
How much is contract W81K0220F0253 worth?
The government has obligated $107,635 on W81K0220F0253.
Which agency awarded contract W81K0220F0253?
Medical Command (Department of the Army) awarded W81K0220F0253, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0220F0253 an order under another contract?
Yes. W81K0220F0253 is a delivery order under V797D70110, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract W81K0220F0253 competed?
The extent of competition for W81K0220F0253 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award